Regulatory Considerations for Probiotic Path-to-Market, Upcoming Webinar Hosted by Xtalks

Share Article

The probiotics market is expected to grow to $76 billion by the year 2024, creating new opportunities for stakeholders within the pharmaceuticals, fermentation, probiotics and nutraceuticals industries. However, confusion over the science and regulation of probiotics may lead to high regulatory risk and a complicated path-to-market strategy. Join this free webinar to learn about US and Canadian regulations that apply to this burgeoning market.

Xtalks Life Science Webinars

The complex nature of probiotics, or live microbial ingredients (LMIs), requires an in-depth understanding of the science in order to effectively navigate the regulatory landscape for probiotics in the US and Canada.

The global probiotic market stands at just over $41 billion USD with a projected growth reaching an all-time high of $76 billion USD by the year 2024. In order to tap into this anticipated growth, probiotic stakeholders should understand the unique regulatory landscape and requirements for introducing new products into the market and maintaining compliance of products already positioned in the marketplace. The complex nature of probiotics, or live microbial ingredients (LMIs), requires an in-depth understanding of the science in order to effectively navigate the regulatory landscape for probiotics in the US and Canada.

Join James Akingbasote, PhD, Regulatory Toxicologist at KGK Science Inc. in a live webinar on Tuesday, January 28, 2020 at 1pm EST to hear about:

  • The regulatory pathways that can be taken by manufacturers of products containing new probiotic strains to introduce them to the US and Canadian markets
  • The major differences in applicable US and Canadian regulations that govern the introduction of new probiotic strains into the respective jurisdiction
  • How to position a new or existing probiotic organism to fit the regulatory requirements of different jurisdictions and reduce regulatory risk;
  • The benefits of hiring a consultant when considering bringing probiotic products into the market

For more information or to register for this event, visit Regulatory Considerations for Probiotic Path-to-Market.

About KGK Science Inc.

As a premium global Contract Research Organization (CRO), KGK Science performs a productive and pioneering role in the realm of scientific study to support the nutraceutical, cannabis and hemp industries. For over two decades, it has offered well-designed, customized solutions to each of its clients, consolidating its scientific, clinical, commercial, and regulatory expertise into one full-service package. Equipped with state-of-the-art technologies, novel research techniques, and a seasoned team of thought leaders, KGK Science remains at the forefront of its industry, seamlessly matching experience with innovation to respond effectively to expanding trade and consumer demands.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Candice Tang
Xtalks
1 (416) 977-6555
Email >
Visit website